Want to see HK:2315 full AI Analyst Report?
ETFs with Biocytogen Pharmaceuticals (Beijing) Co. Ltd. Class H (2315) Exposure
The following ETFs maintain exposure to Biocytogen Pharmaceuticals (Beijing) Co. Ltd. Class H (HK:2315). ETF holdings data are updated periodically, based on the latest holdings the ETFs report, and are subject to change. To see a complete breakdown of any of the ETFs included in the table below, including asset class, AUM, and country allocations, click on the ticker symbol.
14 ETFs Hold Biocytogen Pharmaceuticals (Beijing) Co. Ltd. Class H (2315)
| Symbol | ETF Name | AUM | Expense Ratio | % Weight in ETF | Market Value | % Weight in 2315 |
|---|---|---|---|---|---|---|
| FEM | First Trust Emerging Markets AlphaDEX Fund | $768.71M | 0.80% | 0.25% | $1.92M | 0.36% |
| EMCR | Xtrackers Emerging Markets Carbon Reduction and Climate Improvers ETF | $56.77M | 0.15% | <0.01% | $4,882.06 | <0.01% |
| GXC | SPDR S&P China ETF | $420.87M | 0.59% | <0.01% | $29.44K | <0.01% |
| CAEM | Avantis CIBC Emerging Markets Equity ETF Trust Unit | $154.94M | ― | <0.01% | $7,489.71 | <0.01% |
| RIEM | L&G Emerging Markets ESG Exclusions Paris AlignedUCITS ETF Accum- USD | $146.06M | 0.21% | <0.01% | $4,882.07 | <0.01% |
| PRAM | Amundi Prime Europe UCITS ETF | $1.01B | 0.25% | <0.01% | $65.68K | 0.01% |
| AVEG | Avantis Emerging Markets Equity Ucits ETF AccumUSD | $312.59M | 0.38% | <0.01% | $7,323.09 | <0.01% |
| BBEM | JPMorgan BetaBuilders Emerging Markets Equity ETF | $823.54M | 0.15% | <0.01% | $18.82K | <0.01% |
| GSEE | Goldman Sachs MarketBeta Emerging Markets Equity ETF | $128.70M | 0.36% | <0.01% | $2,382.44 | <0.01% |
| DFAE | Dimensional Emerging Core Equity Market ETF | $9.42B | 0.29% | <0.01% | $45.50K | <0.01% |
| AVEM | Avantis Emerging Markets Equity ETF | $27.48B | 0.33% | <0.01% | $91.44K | 0.02% |
| WEBN | Amundi Prime All Country World UCITS ETF Accum- USD | $3.86B | 0.12% | <0.01% | $27.24K | <0.01% |
| PACW | Amundi Prime All Country World UCITS ETF USD | $5.91B | 0.12% | <0.01% | $27.24K | <0.01% |
| WEHG | Amundi Prime All Country World UCITS ETF Hedged GBP | $35.81M | 0.15% | <0.01% | $27.24K | <0.01% |
| Symbol | % Weight in ETF | ETF Name | AUM | Expense Ratio | Market Value | % Weight in 2315 |
|---|---|---|---|---|---|---|
| FEM | 0.25% | First Trust Emerging Markets AlphaDEX Fund | $768.71M | 0.80% | $1.92M | 0.36% |
| EMCR | <0.01% | Xtrackers Emerging Markets Carbon Reduction and Climate Improvers ETF | $56.77M | 0.15% | $4,882.06 | <0.01% |
| GXC | <0.01% | SPDR S&P China ETF | $420.87M | 0.59% | $29.44K | <0.01% |
| CAEM | <0.01% | Avantis CIBC Emerging Markets Equity ETF Trust Unit | $154.94M | ― | $7,489.71 | <0.01% |
| RIEM | <0.01% | L&G Emerging Markets ESG Exclusions Paris AlignedUCITS ETF Accum- USD | $146.06M | 0.21% | $4,882.07 | <0.01% |
| PRAM | <0.01% | Amundi Prime Europe UCITS ETF | $1.01B | 0.25% | $65.68K | 0.01% |
| AVEG | <0.01% | Avantis Emerging Markets Equity Ucits ETF AccumUSD | $312.59M | 0.38% | $7,323.09 | <0.01% |
| BBEM | <0.01% | JPMorgan BetaBuilders Emerging Markets Equity ETF | $823.54M | 0.15% | $18.82K | <0.01% |
| GSEE | <0.01% | Goldman Sachs MarketBeta Emerging Markets Equity ETF | $128.70M | 0.36% | $2,382.44 | <0.01% |
| DFAE | <0.01% | Dimensional Emerging Core Equity Market ETF | $9.42B | 0.29% | $45.50K | <0.01% |
| AVEM | <0.01% | Avantis Emerging Markets Equity ETF | $27.48B | 0.33% | $91.44K | 0.02% |
| WEBN | <0.01% | Amundi Prime All Country World UCITS ETF Accum- USD | $3.86B | 0.12% | $27.24K | <0.01% |
| PACW | <0.01% | Amundi Prime All Country World UCITS ETF USD | $5.91B | 0.12% | $27.24K | <0.01% |
| WEHG | <0.01% | Amundi Prime All Country World UCITS ETF Hedged GBP | $35.81M | 0.15% | $27.24K | <0.01% |
Popular ETF Comparisons
2315 ETF Exposure FAQ
What ETFs hold Biocytogen Pharmaceuticals (Beijing) Co. Ltd. Class H stock?
Biocytogen Pharmaceuticals (Beijing) Co. Ltd. Class H (HK:2315) is currently held by 14 ETFs in TipRanks’ ETF exposure database. The ETF(s) with exposure to HK:2315 include First Trust (FEM), Amundi (GB:PRAM) and Dimensional (DFAE).
Which ETF has the largest exposure to HK:2315?
The ETF with the largest exposure to HK:2315 is First Trust (FEM), with approximately HKD 1.92M in market value exposure.
How much HK:2315 stock is held by ETFs?
ETFs currently hold approximately HKD 2.11M worth of Biocytogen Pharmaceuticals (Beijing) Co. Ltd. Class H (HK:2315) stock, based on TipRanks’ ETF exposure data.
How often is ETF exposure data updated?
ETF exposure data is updated periodically based on the latest available ETF holdings and reporting data. Actual ETF positions may change between reporting periods.